Further clinical experience with octoclothepin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy*; D003988:Dibenzothiepins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010546:Perphenazine / Q000008:administration & dosage; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects
D003988:Dibenzothiepins; D014149:Tranquilizing Agents; D010546:Perphenazine